Hossenbaccus, Lubnaa
Walker, Terry
Ellis, Anne K.
Article History
Received: 8 October 2024
Accepted: 14 November 2024
First Online: 28 January 2025
Declarations
:
: Not applicable.
: No applicable.
: In the past 36 months, Dr. Anne K. Ellis has participated in advisory boards for ALK Abello, AstraZeneca, Bausch Health, LEO Pharma, Miravo, Merck, Novartis, has been a speaker for ALK Abello, AstraZeneca, Bausch, Miravo, Medexus, Mylan, Novartis, Pfizer, Sanofi, StallergenesGreer and Regeneron. Her institution has received research grants from ALK Abello, Aralez, AstraZeneca, Bayer LLC, Medexus, Novartis, Sanofi and Regeneron. She has also served as an independent consultant to Bayer LLC, Pharming, and Regeneron.The other authors have nothing to declare. The other authors have nothing to declare.